These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 27848924

  • 1. Immunoanalytical characteristics of fecal calprotectin.
    Desbène C, Gaillard O, Kapel N.
    Ann Biol Clin (Paris); 2016 Dec 01; 74(6):725-734. PubMed ID: 27848924
    [Abstract] [Full Text] [Related]

  • 2. [Fecal Calprotectin in Inflammatory Bowel Disease].
    Lee J.
    Korean J Gastroenterol; 2016 May 25; 67(5):233-7. PubMed ID: 27206433
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.
    Kristensen V, Malmstrøm GH, Skar V, Røseth A, Moum B.
    Scand J Gastroenterol; 2016 May 25; 51(5):548-55. PubMed ID: 26634305
    [Abstract] [Full Text] [Related]

  • 5. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM, Nisihara RM, Marion SB, Cavassani MF, Kotze PG.
    Arq Gastroenterol; 2015 May 25; 52(1):50-4. PubMed ID: 26017083
    [Abstract] [Full Text] [Related]

  • 6. Role of fecal calprotectin in the assessment of intestinal inflammation in children with familial Mediterranean fever.
    Gucenmez OA, Kume T, Makay B, Babayigit O, Arslan N, Unsal E.
    Int J Rheum Dis; 2018 Oct 25; 21(10):1844-1848. PubMed ID: 30345692
    [Abstract] [Full Text] [Related]

  • 7. Fecal calprotectin in healthy term and preterm infants.
    Nissen AC, van Gils CE, Menheere PP, Van den Neucker AM, van der Hoeven MA, Forget PP.
    J Pediatr Gastroenterol Nutr; 2004 Jan 25; 38(1):107-8. PubMed ID: 14676607
    [No Abstract] [Full Text] [Related]

  • 8. Interest of fecal calprotectine dosage in inflammatory bowel diseases, state of the art and perspectives.
    Chaabouni T, Manceau H, Peoc'h K.
    Ann Biol Clin (Paris); 2016 Aug 01; 74(4):385-94. PubMed ID: 27492691
    [Abstract] [Full Text] [Related]

  • 9. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E, Severs M, Schipper ME, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.
    J Crohns Colitis; 2015 Jan 01; 9(1):50-5. PubMed ID: 25518048
    [Abstract] [Full Text] [Related]

  • 10. The use of fecal calprotectin and lactoferrin in patients with IBD. Review.
    Stragier E, Van Assche G.
    Acta Gastroenterol Belg; 2013 Sep 01; 76(3):322-8. PubMed ID: 24261027
    [Abstract] [Full Text] [Related]

  • 11. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.
    Bunn SK, Bisset WM, Main MJ, Gray ES, Olson S, Golden BE.
    J Pediatr Gastroenterol Nutr; 2001 Jul 01; 33(1):14-22. PubMed ID: 11479402
    [Abstract] [Full Text] [Related]

  • 12. Fecal calprotectin as a promising marker of inflammatory diseases.
    Paduchova Z, Durackova Z.
    Bratisl Lek Listy; 2009 Jul 01; 110(10):598-602. PubMed ID: 20017448
    [Abstract] [Full Text] [Related]

  • 13. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome.
    Sydora MJ, Sydora BC, Fedorak RN.
    J Crohns Colitis; 2012 Mar 01; 6(2):207-14. PubMed ID: 22325175
    [Abstract] [Full Text] [Related]

  • 14. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul 01; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 15. The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis.
    Önal İK, Beyazit Y, Şener B, Savuk B, Özer Etık D, Sayilir A, Öztaş E, Torun S, Özderın Özın Y, Tunç Demırel B, Ülker A, Dağli Ü.
    Turk J Gastroenterol; 2012 Jul 01; 23(5):509-14. PubMed ID: 23161295
    [Abstract] [Full Text] [Related]

  • 16. Faecal calprotectin: a marker of inflammation throughout the intestinal tract.
    Summerton CB, Longlands MG, Wiener K, Shreeve DR.
    Eur J Gastroenterol Hepatol; 2002 Aug 01; 14(8):841-5. PubMed ID: 12172403
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic value of calprotectin in irritable bowel syndrome and in inflammatory bowel disease.
    Grad C, David L, Portincasa P, Dumitraşcu DL.
    Rom J Intern Med; 2012 Aug 01; 50(1):3-6. PubMed ID: 22788087
    [Abstract] [Full Text] [Related]

  • 18. Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease.
    Mirsepasi-Lauridsen HC, Bachmann Holmetoft U, Ingdam Halkjær S, Angeliki Krogfelt K, Munk Petersen A.
    Scand J Gastroenterol; 2016 Aug 01; 51(2):211-7. PubMed ID: 26359672
    [Abstract] [Full Text] [Related]

  • 19. Fecal calprotectin in inflammatory bowel diseases: update and perspectives.
    Manceau H, Chicha-Cattoir V, Puy H, Peoc'h K.
    Clin Chem Lab Med; 2017 Mar 01; 55(4):474-483. PubMed ID: 27658156
    [Abstract] [Full Text] [Related]

  • 20. Fecal Calprotectin as a Screening Marker for Inflammatory Bowel Disease.
    Sridhar M, Kesavelu D.
    Indian Pediatr; 2019 Mar 15; 56(3):249-250. PubMed ID: 30955002
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.